18.06 USD
-0.74 (-3.94%)
17.97 USD
-0.09 (-0.5%)
ChartMill assigns a Buy % Consensus number of 87% to NGNE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 60.18. This target is 233.22% above the current price.
- NGNE was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about NGNE.
- In the previous month the buy percentage consensus was at a similar level.
- NGNE was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-17 | Craig-Hallum | Initiate | Buy |
| 2025-06-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-05-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-05-16 | Baird | Downgrade | Outperform -> Neutral |
| 2025-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-14 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-20 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-11-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-12 | Stifel | Maintains | Buy -> Buy |
| 2024-11-12 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-27 | BMO Capital | Initiate | Outperform |
| 2024-06-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-11 | Baird | Initiate | Outperform |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-29 | Leerink Partners | Initiate | Outperform |
| 2024-03-21 | William Blair | Initiate | Outperform |
| 2024-03-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
NEUROGENE INC / NGNE FAQ
What is the price target for NGNE stock?
12 analysts have analysed NGNE and the average price target is 60.18 USD. This implies a price increase of 233.22% is expected in the next year compared to the current price of 18.06.
What is the consensus rating for NGNE stock?
The consensus rating for NEUROGENE INC (NGNE) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for NEUROGENE INC stock?
The number of analysts covering NEUROGENE INC (NGNE) is 12.